Literature DB >> 22342403

Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study.

Maarten Verregghen1, Harry G Heijerman, Monique Reijers, Jakko van Ingen, Cornelis K van der Ent.   

Abstract

Mycobacterium abscessus is a nontuberculous mycobacterium that is increasingly recognized as an opportunistic pathogen in cystic fibrosis (CF) patients. Factors that predispose CF patients to infection by this environmental bacterium remain unknown. In a case-control study of 22 CF patients with M. abscessus infection and 22 CF controls, we investigated risk factors for MAB infection as well as the positioning of MAB infection in relation to the other pathogens infecting CF patients. No clear risk factors were found; steroid treatment and CF related diabetes were equally common among cases and controls. M. abscessus disease affects CF patients of varying age, lung function and co-morbidities. Antimicrobial maintenance therapy did not prevent M. abscessus infection. A history of Stenotrophomonas maltophilia infection was significantly more frequent among cases than among controls and there may be a relation with Aspergillus fumigatus infection, or both may be signs of advanced lung damage that predisposes to MAB disease. The absence of clear risk factors and the omnipresence of MAB in the environment suggest that MAB infection in CF patients is a random event. Its symptoms and impact on lung function seem to warrant treatment.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342403     DOI: 10.1016/j.jcf.2012.01.006

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  11 in total

1.  THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds.

Authors:  Adrian Richter; Tirosh Shapira; Yossef Av-Gay
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Leticia Monin; Shail Mehta; Waleed Elsegeiny; Radha Gopal; Jeremy P McAleer; Tim D Oury; Jay Kolls; Shabaana A Khader
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 3.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

4.  The first structure of a mycobacteriophage, the Mycobacterium abscessus subsp. bolletii phage Araucaria.

Authors:  Mohamed Sassi; Cecilia Bebeacua; Michel Drancourt; Christian Cambillau
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

5.  Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.

Authors:  Clair L Preece; Thomas A Wichelhaus; Audrey Perry; Amanda L Jones; Stephen P Cummings; John D Perry; Michael Hogardt
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

6.  Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan.

Authors:  Kazuki Takano; Daishi Shimada; Shota Kashiwagura; Yasuhiro Kamioka; Maya Hariu; Yuji Watanabe; Masafumi Seki
Journal:  Int Med Case Rep J       Date:  2021-07-12

7.  Nontuberculous mycobacteria in respiratory samples from patients with pulmonary tuberculosis in the state of Rondônia, Brazil.

Authors:  Cleoni Alves Mendes de Lima; Harrison Magdinier Gomes; Maraníbia Aparecida Cardoso Oelemann; Jesus Pais Ramos; Paulo Cezar Caldas; Carlos Eduardo Dias Campos; Márcia Aparecida da Silva Pereira; Fátima Fandinho Onofre Montes; Maria do Socorro Calixto de Oliveira; Philip Noel Suffys; Maria Manuela da Fonseca Moura
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-06       Impact factor: 2.743

8.  Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.

Authors:  Dilek Satana; Gonca Erkose-Genc; Zeynep Tamay; Meltem Uzun; Nermin Guler; Zayre Erturan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-13       Impact factor: 3.944

9.  Glby, Encoded by MAB_3167c, Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity.

Authors:  Christos Galanis; Emily C Maggioncalda; Pankaj Kumar; Gyanu Lamichhane
Journal:  J Bacteriol       Date:  2022-04-05       Impact factor: 3.476

10.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.

Authors:  R Andres Floto; Kenneth N Olivier; Lisa Saiman; Charles L Daley; Jean-Louis Herrmann; Jerry A Nick; Peadar G Noone; Diana Bilton; Paul Corris; Ronald L Gibson; Sarah E Hempstead; Karsten Koetz; Kathryn A Sabadosa; Isabelle Sermet-Gaudelus; Alan R Smyth; Jakko van Ingen; Richard J Wallace; Kevin L Winthrop; Bruce C Marshall; Charles S Haworth
Journal:  Thorax       Date:  2016-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.